Samsrita Labs — 360° view

Samsrita Labs, a company in the Healthcare Service Provider industry, reported revenue of ₹0.02 crore and a net loss of ₹0.48 crore for the March 2026 quarter.

Samsrita Labs (BSE: SAMSRITA) closed at ₹11.50 on 20 Nov 2026, down 48.0% over the past year. Its market capitalisation is ₹26 crore.

Share price
₹11.50 (20 Nov 2026)
Market cap
₹26 Cr (20 Nov 2026)
Revenue
₹0 Cr (March 2026 quarter)
Net profit
₹-0 Cr (March 2026 quarter)
ROCE
-62.4% (FY26)
ROE
-68.8% (FY26)
Book value
₹4.96 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹24.50 / ₹10.15 (20 Nov 2026)
1-year return
-48.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: SAMSRITA

Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.